A critical advance in cancer study is occurring with the use of VHH fragments to re-engage dysfunctional p53. This crucial malignant protector protein is frequently lost in various types of malignancies, leading https://bookmarkingfeed.com/story21836577/nanobodies-restore-tumor-suppressor-p53-the-promising-hope-for-tumor-treatment